Concepedia
Statistics
Publications
28
Citations
2.5K
H-Index
22
Active since
1969
Affiliations
University of California San Diego(Current)
University of California, Los Angeles
Ludwig Cancer Research
Saint John's Health Center
Howard Hughes Medical Institute
Ivan Babić is an author at University of California San Diego specializing in oncology, medicine, and molecular oncology.
Publications per year
1969–2024
An LXR Agonist Promotes Glioblastoma Cell Death through Inhibition of an EGFR/AKT/SREBP-1/LDLR–Dependent Pathway
Deliang Guo, Felicia Reinitz, Mary Youssef et al. · Cancer Discovery · 2011 · 447 citations · Full text
Medicine, Oncology, Pharmacology +17
mTOR Complex 2 Controls Glycolytic Metabolism in Glioblastoma through FoxO Acetylation and Upregulation of c-Myc
Kenta Masui, Kazuhiro Tanaka, David Akhavan et al. · Cell Metabolism · 2013 · 400 citations · Full text
Medicine, Cancer Biology, Oncology +16
Oncogenic EGFR Signaling Activates an mTORC2–NF-κB Pathway That Promotes Chemotherapy Resistance
Kazuhiro Tanaka, Ivan Babić, David A. Nathanson et al. · Cancer Discovery · 2011 · 279 citations · Full text
Medicine, Cancer Biology, Oncology +17
EGFR Mutation-Induced Alternative Splicing of Max Contributes to Growth of Glycolytic Tumors in Brain Cancer
Ivan Babić, Erik S. Anderson, Kazuhiro Tanaka et al. · Cell Metabolism · 2013 · 165 citations · Full text
Medicine, Genetics, Oncology +14
De-Repression of <i>PDGFRβ</i> Transcription Promotes Acquired Resistance to EGFR Tyrosine Kinase Inhibitors in Glioblastoma Patients
David Akhavan, Alexandra L. Pourzia, Alex Nourian et al. · Cancer Discovery · 2013 · 142 citations · Full text
1–5 of 28